Innovations for Changing the Face of Women’s Reproductive Health Therapeutics

At ObsEva, our passion and expertise in reproductive health and pregnancy therapeutics is helping millions of women worldwide lead healthier and more fulfilling lives.

Significant Unmet Needs in Reproductive Health

Millions of women worldwide suffer from reproductive health conditions that affect their quality of life or ability to conceive and may lead to complications during pregnancy.

Innovation From Conception to Birth and Beyond

ObsEva is advancing a robust pipeline of novel, orally-administered, clinical-stage compounds in the areas of uterine fibroids, endometriosis, assisted reproductive technology, and preterm labor.

Recent Updates

18 May 2017

ObsEva Reports First Quarter 2017 Financial Results and Business Update

Read More
18 May 2017

ObsEva Announces the Completion of a Phase 1 Drug-Drug Interaction Study with OBE022

Read More
16 May 2017

ObsEva SA to Attend BioEquity Europe 2017 in Paris

Read More
11 May 2017

Q1 2017 ObsEva SA Earnings Conference Call

Read More